105 related articles for article (PubMed ID: 2714917)
1. Kinetics of antipyrine and sulfamethazine in patients recovered from dihydralazine-hepatitis.
Siegmund W; Franke G; Baumgarten R; Fengler JD; Krüger R; Reichardt R
Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):165-9. PubMed ID: 2714917
[TBL] [Abstract][Full Text] [Related]
2. [Biotransformation in patients following Depressan-induced hepatitis].
Hoffmann A; Reinhardt M; Rechenbach C; Henschel L; Jorke D
Gastroenterol J; 1989; 49(1):8-11. PubMed ID: 2765156
[TBL] [Abstract][Full Text] [Related]
3. The influence of the acetylator phenotype for the clinical use of dihydralazine.
Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694
[TBL] [Abstract][Full Text] [Related]
4. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
[TBL] [Abstract][Full Text] [Related]
5. [Chronic drug-induced hepatitis caused by dihydralazine].
Roschlau G; Hass S; Schmehl V
Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):41-6. PubMed ID: 3371237
[TBL] [Abstract][Full Text] [Related]
6. [Dihydralazine-induced acute hepatitis with IgM deficiency].
Knoblauch M; Cueni B; Spycher M; Schmid M
Schweiz Med Wochenschr; 1977 May; 107(19):651-6. PubMed ID: 867010
[TBL] [Abstract][Full Text] [Related]
7. Effects of nocloprost (9 beta-chloro-16,16-dimethyl PG E2) on absorption and disposition of antipyrine and sulfamethazine in healthy volunteers.
Siegmund W; Zschiesche M; Franke G; Müller C; Amon I
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):190-7. PubMed ID: 8500921
[TBL] [Abstract][Full Text] [Related]
8. [Drug-induced hepatitis after dihydralazine treatment with fatal consequences].
Machnik G; Bergert A; Justus J; Kunze P; Müller R; Reinhardt M; Schulz H; Stein G; Thiele R
Zentralbl Allg Pathol; 1988; 134(2):167-77. PubMed ID: 3420978
[TBL] [Abstract][Full Text] [Related]
9. Dihydralazine therapy and acetylator phenotype.
Iisalo E; Laine T; Lehtonen A; Sellman R
Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
[TBL] [Abstract][Full Text] [Related]
10. [Acute hepatitis caused by dihydralazine].
Boccaccio F; Attali P; Nataf J; Ink O; Fabre M; Pelletier G
Gastroenterol Clin Biol; 1987; 11(8-9):614. PubMed ID: 3653625
[No Abstract] [Full Text] [Related]
11. Dihydralazine hepatitis: report of a case and review of the literature.
Pariente EA; Pessayre D; Bernuau J; Degott C; Benhamou JP
Digestion; 1983; 27(1):47-52. PubMed ID: 6884586
[TBL] [Abstract][Full Text] [Related]
12. [Dihydralazine-induced hepatitis].
Schweiz Med Wochenschr; 1977 May; 107(19):649-50. PubMed ID: 867009
[No Abstract] [Full Text] [Related]
13. [Acute liver damage in patients treated with a depressant (dihydralazine sulfate)].
László B; Kendrey G
Orv Hetil; 1981 Dec; 122(52):3197-200. PubMed ID: 7329695
[No Abstract] [Full Text] [Related]
14. [The so-called dihydralazine hepatitis. A contribution to the pathogenesis].
Reinhardt M; Machnik G; Krombholz B; Jahn G
Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):283-94. PubMed ID: 4092653
[TBL] [Abstract][Full Text] [Related]
15. [Liver lesions induced by dihydralazine and propranolol].
Kunze KD; Porst H; Lohmann J; Tschöpel L
Zentralbl Allg Pathol; 1985; 130(1):19-29. PubMed ID: 3984541
[TBL] [Abstract][Full Text] [Related]
16. [Dihydralazine-induced hepatitis with bridging necrosis. A clinico-pathologic survey of 20 cases].
Roschlau G
Zentralbl Allg Pathol; 1983; 127(5-6):385-93. PubMed ID: 6880446
[TBL] [Abstract][Full Text] [Related]
17. [Drug-induced hepatitis in a diabetic patient].
Kantola I; Viikari J; Leino R; Seppälä P
Duodecim; 1985; 101(6):587-90. PubMed ID: 3987570
[No Abstract] [Full Text] [Related]
18. [Dihydralazine hepatitis].
Colombel JF; Cortot A; Houcke M; Prin L; Dessaint JP; Gerard A; Paris JC
Presse Med; 1985 Mar; 14(9):552. PubMed ID: 3157181
[No Abstract] [Full Text] [Related]
19. [Quantitative determination and kinetics of dihydralazine in hypertension patients].
Siegmund W; Zschiesche M; Kallwellis R; Franke G; Schneider T; Sill U; Scherber A; Hüller H
Pharmazie; 1985 Nov; 40(11):779-81. PubMed ID: 4095128
[TBL] [Abstract][Full Text] [Related]
20. [Morphology and pathogenesis of liver injury produced by dihydralazine , propranolol and ketophenylbutazone].
Kunze KD; Porst H; Tschöpel L
Zentralbl Allg Pathol; 1985; 130(6):509-18. PubMed ID: 3841742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
